Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Targeted metabolomics provides an approach to quantify metabolites involved in specific molecular pathways. We applied an electrochemistry-based, targeted metabolomics platform to define changes in tryptophan, tyrosine, purine and related pathways in the depressed and remitted phases of major depressive disorder (MDD). Biochemical profiles in the cerebrospinal fluid of unmedicated depressed (n = 14; dMDD) or remitted MDD subjects (n = 14; rMDD) were compared against those in healthy controls (n = 18; HC). The rMDD group showed differences in tryptophan and tyrosine metabolism relative to the other groups. The rMDD group also had higher methionine levels and larger methionine-to-glutathione ratios than the other groups, implicating methylation and oxidative stress pathways. The dMDD sample showed nonsignificant differences in the same direction in several of the metabolic branches assessed. The reductions in metabolites associated with tryptophan and tyrosine pathways in rMDD may relate to the vulnerability this population shows for developing depressive symptoms under tryptophan or catecholamine depletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The same group of patients also showed changes in the methionine-to-glutathione ratio, indicating alterations in OS and methylation.”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [467]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An analysis of the tryptophan, tyrosine, purine pathways, and associated pathways revealed that in patients in remission, methionine levels were higher, while tryptophan and tyrosine levels were lower.”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [467]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The levels of these same metabolites were altered in MDD patients who were not taking medication, although not to a significant degree. 467”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [467]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametrics: Statistical Methods Based on Ranks
Mergenthaler, M. J., & Lehmann, E. L. (1979) · Technometrics · doi:10.2307/1268531 · Cited by 3,329
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307
Limbic-cortical dysregulation: a proposed model of depression
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.471 · Cited by 1,585
Discovering Endophenotypes for Major Depression
Hasler, G., Drevets, W. C., Manji, H. K., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300506 · Cited by 1,123
Self-citationMetabolomics: A Global Biochemical Approach to Drug Response and Disease
Kaddurah-Daouk, R., Kristal, B. S., & Weinshilboum, R. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094715 · Cited by 670
Self-citationGawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594
GABAergic dysfunction in mood disorders
Brambilla, P., Perez, J., Barale, F., Schettini, G., & Soares, J. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001362 · Cited by 553
The implications of human metabolic network topology for disease comorbidity
Lee, D.-S., Park, J., Kay, K. A., Christakis, N. A., Oltvai, Z. N., & Barabási, A.-L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802208105 · Cited by 495
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Stahl, S. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0103 · Cited by 489
Research works printed but not linked: 3
- Delgado, P. L. Depression: the case for a monoamine deficiency. J Clin Psychiatry 61 Suppl 6, 7–11 (2000).
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition. Washington, DC American Psychiatric Association; 1994.
- First, M. B., Spitzer, R. L., Gibbon, M. & William, J. B. W. Structured Clinical Interview fpr DSM-IV-TR Axis 1 disorders, Research Version, Patient Edition (SCID-I/P) New York, NY: New York State Psychiatric Institute, Biometric research; 2002. 73 Maxwell, M. (Bethesda, MD, 1992).
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
Effects of pre-analytical processes on blood samples used in metabolomics studies
Yin, P., Lehmann, R., & Xu, G. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8565-x · Cited by 278
Savitz, J., Drevets, W. C., Wurfel, B. E., Ford, B. N., Bellgowan, P. S. F., Victor, T. A., Bodurka, J., Teague, T. K., & Dantzer, R. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.02.007 · Cited by 209
“Further, a reduction in the 5-hydroxyindoleacetic acid to kynurenine ratio was found in the cerebrospinal fluid of unmedicated rMDD patients compared with both dMDD patients and HCs, suggesting greater shunting of TRP away from serotonin synthesis towards the kynurenine metabolic pathway (Kaddurah-Daouk et al., 2012).”
ResultSelf-citationPharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology
Kaddurah-Daouk, R., & Weinshilboum, R. M. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.217 · Cited by 188
Self-citationThe Glutathione System: A New Drug Target in Neuroimmune Disorders
Morris, G., Anderson, G., Dean, O., Berk, M., Galecki, P., Martin-Subero, M., & Maes, M. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8705-x · Cited by 187
“3 months without medication to be included [250].”
BackgroundResult
Metadata
- Authors
- Kaddurah-Daouk, R., Yuan, P., Boyle, S. H., Matson, W., Wang, Z., Zeng, Z. B., Zhu, H., Dougherty, G. G., Yao, J. K., Chen, G., Guitart, X., Carlson, P. J., Neumeister, A., Zarate, C., Krishnan, R. R., Manji, H. K., & Drevets, W.
- Affiliations
- Duke University (US)
- National Institutes of Health (US)
- Edith Nourse Rogers Memorial Veterans Hospital (US)
- North Carolina State University (US)
- VA Pittsburgh Healthcare System (US)
- National University of Singapore (SG)
- Corresponding author
- Kaddurah-Daouk, Rima
- ORCID
- Venue
- Scientific Reports
- Published
- 2012-09-19
- Volume
- 2
- Issue
- 1
- Pages
- 667-667
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3446657
- OpenAlex
- W1971315623
- Cited by
- 76
- References
- 77
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 9 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 9 · 2018: 6 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 6 · 2013: 5 · 2012: 1
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health
- National Institute of Mental Health
- National Institute of General Medical Sciences (R24GM078233)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- major depressive disorder, remission, tryptophan metabolism, tyrosine metabolism, purine metabolism, methionine, methylation, oxidative stress, catecholamine depletion, depression vulnerability
- MeSH terms
- Adult, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Remission, Spontaneous, Severity of Illness Index, Biogenic Monoamines, Multivariate Analysis, Case-Control Studies, Biosynthetic Pathways, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile. https://app.cochat.ai/papers/10.1038/srep00667
- The paper
- Kaddurah-Daouk, R., Yuan, P., Boyle, S. H., Matson, W., Wang, Z., Zeng, Z. B., Zhu, H., Dougherty, G. G., Yao, J. K., Chen, G., Guitart, X., Carlson, P. J., Neumeister, A., Zarate, C., Krishnan, R. R., Manji, H. K., & Drevets, W. (2012). Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile. Scientific Reports. https://doi.org/10.1038/srep00667
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.